| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 74, 685-689, Copyright © 1992 by Endocrine Society
ARTICLES |
S Jaresch, E Kornely, HK Kley and R Schlaghecke
Department of Endocrinology, Internal Medicine, Heinrich Heine University of Duesseldorf, Germany.
Adrenal tumors are being detected more frequently in consequence of the wider application of increasingly sensitive radiological investigation techniques. According to the working hypothesis that more silent adenomas could develop from hyperplastic tissue areas under increased stimulation of the adrenal cortex, heterozygous and homozygous patients with congenital adrenal hyperplasia (CAH) were studied. A high incidence of adrenal masses, nearly 82% in homozygous and 45% in heterozygous patients, was found. There was no correlation between tumor size and serum 17-hydroxyprogesterone concentrations. These tumors are, therefore, probably silent adenomas. On the basis of these results, CAH should always be ruled out in the case of incidentally detected adrenal masses. Since CAH is a relatively frequent disease, and the adrenal carcinoma belongs to the rarest malignant tumors, a malignant transformation of these tumors seems to be unlikely.
This article has been cited by other articles:
 |
|
 |
|
  P. S. H. Soon, K. L. McDonald, B. G. Robinson, and S. B. Sidhu Molecular Markers and the Pathogenesis of Adrenocortical Cancer Oncologist, May 1, 2008; 13(5): 548 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Libe and J. Bertherat Molecular genetics of adrenocortical tumours, from familial to sporadic diseases Eur. J. Endocrinol., October 1, 2005; 153(4): 477 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management Endocr. Rev., April 1, 2004; 25(2): 309 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Merke, S. R. Bornstein, N. A. Avila, and G. P. Chrousos Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Ann Intern Med, February 19, 2002; 136(4): 320 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bourdeau, P. D'Amour, P. Hamet, J.-M. Boutin, and A. Lacroix Aberrant Membrane Hormone Receptors in Incidentally Discovered Bilateral Macronodular Adrenal Hyperplasia with Subclinical Cushing's Syndrome J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5534 - 5540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr. Rev., June 1, 2000; 21(3): 245 - 291. [Abstract] [Full Text]
|
|
|
|
|
|
F. Beuschlein, E. Schulze, P. Mora, H.-P. Gensheimer, C. Maser-Gluth, B. Allolio, and M. Reincke Steroid 21-Hydroxylase Mutations and 21-Hydroxylase Messenger Ribonucleic Acid Expression in Human Adrenocortical Tumors J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2585 - 2588. [Abstract] [Full Text]
|
|
|
|
|
|
L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macri’, and M. Boscaro Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 55 - 62. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Azziz and S. M. Slayden The 21-Hydroxylase-Deficient Adrenal Hyperplasias: More Than ACTH Oversecretion Reproductive Sciences, November 1, 1996; 3(6): 297 - 302. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Nasir and C. Walton Lesson of the Week: Adrenal mass with virilisation: importance of endocrine investigation BMJ, October 5, 1996; 313(7061): 872 - 873. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
